Journal
CANCER
Volume 110, Issue 9, Pages 1900-1910Publisher
WILEY
DOI: 10.1002/cncr.23000
Keywords
acute myeloid leukemia; new agents; risk stratification; therapy
Categories
Ask authors/readers for more resources
Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regimens combining cytotoxic agents for the treatment of patients with AML. Current research is attempting to better stratify, patients by identifying risk factors responsible for resistance, and to discern ways for incorporating newer agents with specific and targeted activity into our standard regimens, Herein the recent developments in the diagnosis and treatment of AML are reviewed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available